Selected Recent Domestic Transactions
in its minority investment
in its consideration of strategic alternatives and response to a proposal by 40 North and entry into an agreement to acquire the Fine Chemistry Services business of
in its acquisition of
in the sale of its Generic Rx business to Altaris Capital Partners
Evernorth Health, a wholly owned subsidiary of Cigna, in its acquisition of
in its response to activism from Starboard Value and associated negotiated resolution
in the merger of its majority owned MLP, Enable Midstream Partners, with
in its acquisition of
in the equity investment by T. Rowe Price and Oberndorf Enterprises in IAC's subsidiary,
in its settlement relating to PFAS liabilities arising out of the period prior to the Chemours spin-off
in its acquisition of
in its merger with
